Ingrid Lange

Ingrid Lange has over 20 years of work experience in the field of biopharmaceutical development. Ingrid currently serves as the Head of Upstream Process Development at Xbrane Biopharma AB, where they started in June 2022. Prior to this, they worked at Sobi - Swedish Orphan Biovitrum AB (publ) as a Subject Matter Expert Drug Substance from May 2020 to June 2022.

Before joining Sobi, Ingrid was the Section Manager of Biopharmaceutical Production at Octapharma from January 2019 to April 2020. Ingrid also has experience working at Cobra Biologics, where they held the roles of Team Manager and Senior Scientist and Scientific Lead from April 2016 to December 2018 and from January 2009 to March 2016, respectively.

Ingrid also has previous experience as a scientist at AstraZeneca BioPR&D from 2006 to 2008 and as a process engineer at Biovitrum AB from 2005 to 2006. Ingrid began their career as a Research Engineer at the Department of Biotechnology, KTH in June 2002, where they worked until August 2003.

Throughout their career, Ingrid has demonstrated leadership skills, managing teams and overseeing the development of production cell lines and cell culture processes. Ingrid emphasizes personal development for their team members and continuously seeks workflow and method improvements. In addition to their technical expertise, they also collaborate closely with business and proposal managers to design development programs for customers.

Overall, Ingrid Lange's work experience showcases their extensive knowledge and expertise in biopharmaceutical development, as well as their ability to lead teams and drive continuous improvement.

Ingrid Lange began their education in 1997 at The Faculty of Engineering at Lund University, where they pursued a degree in Chemical Engineering. Ingrid completed their MSc in Chemical Engineering in 2002. During this time, in 2000-2001, they also spent a year studying Biotechnology at Queen's University, although the degree obtained is not specified. In 2002, Ingrid joined the KTH Royal Institute of Technology, where they pursued a Licentiate degree in Biotechnology, completing it in 2005.